Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
What key factors are powering the surge in the hyperimmune globulins market right now?
In recent times, there has been significant growth in the size of the hyperimmune globulins market. The market, which was valued at $1.91 billion in 2024, is expected to expand to $2.06 billion in 2025 with a compound annual growth rate (CAGR) of 7.8%. The notable growth during the historic phase can be traced back to increased government aid and a surge in spending on healthcare.
How fast Is the hyperimmune globulins market expected to grow, and what’s its future value?
The market size of hyperimmune globulins is anticipated to witness robust expansion in the coming years, rising to a valuation of $2.76 billion in 2029, courtesy of a compound annual growth rate (CAGR) of 7.6%. This expansion over the forecast period can be credited to a surge in infectious diseases, increased understanding of the advantages of hyperimmune globulin injections, heightened demand for immunoglobulins, escalating prevalence of alpha-1 antitrypsin deficiency, and growing cases of immune deficiencies. The forecast period is also expected to see significant trends such as technological and innovative advancements, investments in R&D, increased demand for passive immunity treatments, progression in plasma-derived therapies, and technological advancements in the manufacturing sector.
Get your hyperimmune globulins market report here!
https://www.thebusinessresearchcompany.com/report/hyperimmune-globulins-global-market-report
What are the leading drivers of growth in the hyperimmune globulins market?
The rising frequency of infectious diseases is anticipated to stimulate the expansion of the hyperimmune globulin market. These diseases are conditions whereby damaging organisms such as viruses, bacteria, fungi, and parasites infiltrate the body. The escalation can be credited to factors like increased antimicrobial resistance, changes in climate, and growth in population size. Hyperimmune globulins are instrumental against infectious diseases due to their ability to provide instant passive immunity by dispensing concentrated antibodies focused against specific pathogens, thus helping in the prevention or cure of diseases like rabies, hepatitis B, or tetanus. For example, in April 2024, the Centers for Disease Control and Prevention, a US government agency, reported that chronic hepatitis B cases in the US escalated approximately 17% from 14,229 cases in 2021 to 16,729 cases in 2022. Consequently, the heightened frequency of infectious diseases is fostering the hyperimmune globulin market’s growth. The anticipation of growth in the hyperimmune globulins market can also be attributed to governmental initiatives focusing on healthcare research and development. The rise in governmental initiatives toward healthcare research and development is due to the increased demand for groundbreaking medical solutions and the urgency to handle budding health hazards. Such government-driven efforts enhance the development and availability of hyperimmune globulins, thereby effectively battling specific infectious diseases. For example, in 2022, the Department of Health and Social Care in the UK confirmed that the UK government pledged £260 million (US $270.65) million to augment research and manufacturing in the healthcare sector. This commitment was made by Business, Energy, and Industrial Strategy (BEIS) and the Department of Health and Social Care (DHSC) to fortify NHS-led health research in diagnostics and treatment, utilizing new platforms that preserve privacy and clinical research services, with an additional £60 million (US $63.60 million) allocated to amplify life sciences manufacturing in the UK. Hence, the surge in governmental initiatives for research and development in healthcare propels the hyperimmune globulins market.
What are the key segments defining the hyperimmune globulins market?
The hyperimmune globulins market covered in this report is segmented –
1) By Type: Hepatitis B Hyperimmune Globulin, Rabies Hyperimmune Globulin, Tetanus Hyperimmune Globulin, Cytomegalovirus (CMV) Hyperimmune Globulin, Varicella-Zoster Virus (VZV) Hyperimmune Globulin, Respiratory Syncytial Virus (RSV) Hyperimmune Globulin, Other Types
2) By Route Of Administration: Intramuscular, Intravenous
3) By Application: Government Institution, Private Sector, Other Applications
Subsegments:
1) By Hepatitis B Hyperimmune Globulin: Intramuscular Hepatitis B Hyperimmune Globulin, Intravenous Hepatitis B Hyperimmune Globulin
2) By Rabies Hyperimmune Globulin: Rabies Immune Globulin (Human), Rabies Immune Globulin (Equine)
3) By Tetanus Hyperimmune Globulin: Tetanus Immune Globulin (Human), Tetanus Immune Globulin (Equine)
4) By Cytomegalovirus (Cmv) Hyperimmune Globulin: Cmv Immune Globulin For Organ Transplantation, Cmv Immune Globulin For Neonatal Infection
5) By Varicella-Zoster Virus (Vzv) Hyperimmune Globulin: Vzv Immune Globulin For Post-Exposure Prophylaxis, Vzv Immune Globulin For Immunocompromised Patients
6) By Respiratory Syncytial Virus (Rsv) Hyperimmune Globulin: Rsv Immune Globulin For Infants And Children, Rsv Immune Globulin For Adults With Respiratory Conditions
7) By Other Types: Diphtheria Hyperimmune Globulin, Botulism Hyperimmune Globulin, Other Specialized Hyperimmune Globulins
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16448&type=smp
Who are the key players steering the development of the hyperimmune globulins market?
Major companies operating in the hyperimmune globulins market are F. Hoffmann-La Roche AG, Bayer AG, Takeda Pharmaceutical Company Limited, Baxter International Inc., CSL Ltd., Fresenius Kabi AG, Grifols SA, Octapharma AG, Shanghai RAAS Blood Products Co. Ltd., Emergent BioSolutions Inc., Kedrion Biopharma Inc., LFB SA, Hualan Biological Engineering Inc., FFF Enterprises Inc., Taibang Biologic Group, Bio Products Laboratory (BPL) Ltd., ADMA Biologics, Cangene Corporation, Kamada Ltd., Saol Therapeutics Inc., Omrix Biopharmaceuticals Ltd., Shire, Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd., BioCare Inc.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16448
Which regions are most influential in expanding the hyperimmune globulins market?
North America was the largest region in the hyperimmune globulins market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hyperimmune globulins market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Automotive Speaker Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/automotive-speaker-global-market-report
Portable Car Vacuum Cleaner Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/portable-car-vacuum-cleaner-global-market-report
Brake System Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/brake-system-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
